JOSE ANTONIO
IRIBARREN LOYARTE
IRAKASLE AGREGATUA
![Foto de JOSE ANTONIO](/img/nophoto.png)
![Foto de Université Denis Diderot](/img/noimage_org.png)
Université Denis Diderot
París, FranciaUniversité Denis Diderot-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2018
-
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial
The Lancet HIV, Vol. 5, Núm. 1, pp. e23-e34
-
Prosthetic Valve Candida spp. Endocarditis: New Insights into Long-term Prognosis-The ESCAPE Study
Clinical Infectious Diseases, Vol. 66, Núm. 6, pp. 825-832
2016
-
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
Clinical Infectious Diseases, Vol. 62, Núm. 5, pp. 655-663